Quantcast

Latest Proton pump inhibitors Stories

2013-01-18 23:02:16

The law firm of d´Oliveira & Associates is working with some of the leading Prilosec lawyers in the country handling Prilosec cases and want the public to know that they offer a “No Win No Fee Promise” for Prilosec users who have suffered osteoporosis-like bone fractures in the wrist, hip, spine, etc. This means that you would pay no legal fee unless and until you receive a settlement or award of your Prilosec claim and/or Prilosec lawsuit. (PRWEB) January 18, 2013...

2013-01-07 05:00:08

Law Firm offers no win - no fee promise for clients injured from Nexium, which has been linked to severe side effects such as osteoporosis, bone deterioration and esophageal cancer. (PRWEB) January 06, 2013 During the week of December 6, 2012, more than 1,000 Nexium bone injury lawsuits were centralized into an MDL in the U.S. District Court for the Central District of California. (In re. Nexium (Esomerprazole) Products Liability Litigation, MDL Docket No. 2404) The plaintiffs in these...

2012-12-25 05:02:53

On December 6th, 2012, 39 lawsuits alleging Nexium caused bone fractures were consolidated in the Multidistrict Litigation MDL 2404 (Central District of California) by the U.S. Judicial Panel. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of alleged Nexium severe adverse events. [http://www.attorneyone.com/nexium-lawsuits/...

2012-09-05 23:04:23

New research study “Gastric Cancer - Brazil, Russia, India and China (BRIC) Drug Forecasts and Treatment Analysis to 2020” prepared by GlobalData has been recently published by Market Publishers Ltd. The report finds that the global gastric cancer drug market will experience robust growth over the next decade. London, UK (PRWEB) September 04, 2012 The global gastric cancer drug market will experience robust growth over the next decade, driven by the rapid uptake and market...

2012-08-31 08:20:01

Eradication by Concomitant Therapy with Proton Pump Inhibitors, Amoxicillin Hydrate and either Clarithromycin or MetronidazoleTokyo/Osaka, Aug 31, 2012 - (JCN Newswire) - Takeda Pharmaceutical Company Limited (Headquarters: Osaka, President: Yasuchika Hasegawa), AstraZeneca K.K. (Headquarters: Osaka, President: Paul Hudson), Mitsubishi Tanabe Pharma Corporation (Headquarters: Osaka; President: Michihiro Tsuchiya), and Eisai Co., Ltd. (Headquarters: Tokyo; President and CEO: Haruo Naito)...

2012-07-16 23:00:45

The findings of the study published in July 2012 on The American Journal of Gastroenterology, revealed a 65% increase in the incidence of clostridium difficile-associated diarrhea (CDAD) among users of PPIs (Proton Pump Inhibitors), including Nexium. Nexium, manufactured by AstraZeneca, is a medication that people take to prevent on-going heartburn. In February 2012, the US FDA issued a drug safety communication notifying the public that the use of stomach acid drugs known as proton pump...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'